Keyword: eye drugs

News

Bausch & Lomb's Ista Pleads Guilty Over Kickbacks

25.05.2013 - Ista Pharmaceuticals pleaded guilty on Friday to charges it used kickbacks and improper marketing to boost sales of a drug meant to treat eye pain and agreed to pay $33.5 million...

News

Fast Climbing Biotech Regeneron Still Has Room to Grow

07.05.2013 - Just two years ago, Regeneron Pharmaceuticals was a relatively obscure biotech company in the village of Tarrytown, a picturesque New York suburb better known for "Rip Van Winkle,"...

News

Shire Boosts Eye Business with $160 Million SARcode Buy

25.03.2013 - Shire is to buy privately owned U.S. biotech firm SARcode Bioscience, paying $160 million upfront to win rights to a new drug in late-stage development for dry eye diseases. The...

News

U.S. Health Advisers Back Two New Eye Treatments

27.07.2012 - A U.S. Food and Drug Administration panel on Thursday recommended two drugs for combating different forms of vision loss that can lead to blindness among a range of adults...

News

Ophthotech Drug May Shake up Eye Treatment Market

14.06.2012 - Competition in the eye drug market is heating up, with an experimental drug from private U.S. biotech Ophthotech showing impressive results when added to Roche's Lucentis in a...